… with moderate to severe COVID-19 (ie, patients requiring … effect of anakinra treatment on
mortality in patients admitted … the effect of anakinra treatment on mortality in patients admitted to …

… is the first patient-level analysis on the effect of anakinra treatment in COVID-19 patients,
which, on the one hand, suggests a significant benefit in the reduction of mortality and on the …

… the efficacy of anakinra on mortality in patients with COVID-19. A … treatment of COVID-19 with
anakinra, compared with placebo or … Finally, this meta-analysis was not patient-level, so the …

… Considering the reduction in both the need for invasive mechanical ventilation and
mortality, our study suggests that anakinra might represent an effective treatment for the …

… We found that Anakinra makes little or no difference to all-cause mortality at up to day 28
compared to placebo or standard care alone (RR 0.96, 95% CI 0.64–1.45; RD 9 fewer per 1000…

… and the day of starting anakinra treatment were examined against outcome measures (duration
of hospital stay, days to defervescence, drop in ferritin level, and mortality) to identify any …

… corticosteroids received anakinra due to a serum level of IL6 … of administering anakinra after
corticosteroids in patients with … mortality rate were lower in the group that received anakinra …

… level of ferritin and/or progressive organ dysfunction with no apparent reason apart from
hyperinflammation). Patients who were not treated with anakinra … to decrease mortality in COVID-…

… individual patient-level meta-analysis in a subgroup of 895 patients… adjusted risk reduction
with the use of anakinra [11]. … ratios for mortality between patients treated with anakinra versus …

… mortality was developed in third of anakinra receiving severe and critical ill COVID-19 patients…
In this study, we aimed to evaluate the predictive factors of mortality in patients with severe …